Results 241 to 250 of about 11,700 (268)
Some of the next articles are maybe not open access.

Photoprotection of the eye in PUVA therapy

British Journal of Dermatology, 1978
Photochemotherapy with psoralens, now widely used in the therapy of psoriasis, vitiligo and mycosis fungoides, has been proposed to have the capacity, during long-term therapy, to induce ocular damage, e.g. cataract. This view is based on animal experiments (Cloud, Hakim & Griffin, 1960, 1961; Free-man & Troll, 1969) and as a consequence adequate ...
openaire   +3 more sources

PUVA therapy of diffuse granuloma annulare

Clinical and Experimental Dermatology, 1988
3 cas de granulome annulaire diffus interessant 20 a 40% de la surface corporelle et de duree variable ont ete traites par la PUVAtherapie.
J.G. Spiro, H. Cochrane, T.C. Hindson
openaire   +3 more sources

Melanocyte changes following PUVA therapy

Journal of the American Academy of Dermatology, 1979
The effect of psoralens and long-wave ultraviolet light (PUVA) therapy on human melanocytes was studied at the ultrastructural level. The results demonstrate an increase in the number of melanocytes, a change in their location, and an increase in the size of the melanosomes.
A.S. Zelickson   +5 more
openaire   +3 more sources

PUVA therapy of chronic actinic dermatitis

British Journal of Dermatology, 1985
Four men with long-standing chronic actinic dermatitis were treated with a modified PUVA regime which initially included generalized applications of topical steroids given immediately after PUVA exposure. All patients are now free of rash, no longer need protection from UV radiation, and are being maintained on twice monthly PUVA therapy (IO J/cm2).
J. Spiro, Colin Hindson, A. Downey
openaire   +3 more sources

Praxis der PUVA-Therapie

2003
Die PUVA-Therapie besteht aus dem kombinierten Einsatz von Psoralenen und UVA-Licht. Zur Zeit stehen Psoralenpraparate mit verschiedenen Eigenschaften zur Verfugung. Auch der Einsatz des UVA-Lichts kann sehr unterschiedlich gehandhabt werden [1, 2, 7, 8, 13]. Da der Therapieerfolg vom praktischen Einsatz dieser Parameter abhangt, fanden wir es sinnvoll,
Frank O. Nestle   +3 more
openaire   +2 more sources

Phototherapy and Puva Therapy

1988
By common usage phototherapy has come to mean the treatment of disease by ultraviolet (UV) or visible radiation either alone or with an added chemical. In dermatology phototherapy is generally restricted to describe treatment of skin disease with UV-B (290–320 nm) and the added chemicals are topically applied coal tar or anthralin.
openaire   +2 more sources

Position paper—PUVA therapy

Journal of the American Academy of Dermatology, 1983
PUVA, the combination of psoralen (P) and long-wave ultraviolet radiation (UVA), is being used increasingly in the management of psoriasis and several other dermatologic disorders. While the acute toxicity of this modality, which includes erythema and blistering of the skin, can be avoided with careful monitoring of the dosimetry of the administered ...
openaire   +2 more sources

Livedoid vasculitis responding to PUVA therapy

International Journal of Dermatology, 2001
AbstractBackground  Livedoid vasculitis is a chronic disorder manifested as recurrent, painful, reticulated, and ulcerative lesions of the legs, which result in ivory atrophic scars with peripheral telangiectasia and hyperpigmentation. Its etiology remains obscure and therapy is difficult.
Seung-Kyung Hann   +4 more
openaire   +3 more sources

An Evaluation of PUVA-Therapy for Alopecia areata

Dermatology, 1984
30 patients with alopecia areata were treated with 8-methoxypsoralen orally combined with whole body UVA exposure. 9 patients showed more than 60% regrowth of hair, 8 of them had recurrences of hair loss within a mean time of 7.7 months. No selecting criteria could be found prophesying good results of PUVA therapy.
W W van der Schaar, J H Sillevis Smith
openaire   +3 more sources

Autografting and PUVA A Combination Therapy for Vitiligo

The Journal of Dermatologic Surgery and Oncology, 1992
A novel approach to the management of vitiligo is described using a combination of epidermal autografts transplanted into the depigmented areas and psoralen‐ultraviolet‐A (PUVA) therapy. Epidermal autografts can be obtained rapidly and in large numbers using a device that combines the synergistic effects of suction and heat on the skin.
Warwick L. Morison   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy